Jump to content

OmniVis

From Wikipedia, the free encyclopedia
OmniVis
IndustryBiotechnology
Founded2017
HeadquartersSan Francisco
Key people
Katherine Clayton, CEO
Websitewww.omnivistech.com
Dr Katherine Clayton of OmniVis at TechCrunch Disrupt San Francisco 2019

OmniVis is a South San Francisco based biotechnology company that specializes in rapid medical diagnostic tests.[1][2][3] Co-founded by Dr. Katherine Clayton, a Purdue College of Engineering graduate alumna, and three professors, OmniVis produces cholera test and is working on COVID-19 tests.

Products

[edit]

Cholera detection

[edit]

OmnniVis's rapid Cholera detection device can identify the presence of Vibrio cholerae in water in less than one hour.[4] The device uses a process of DNA amplification and viscosity measurement.[5]

The processing is done via a smartphone enabled platform that analyzes water samples inserted into a single-use test kit element.[1] In May 2019, OmniVis teamed up with the International Cetre for Diarrhoeal Disease Research, Bangladesh to beta test the technology.[1]

COVID-19 detection

[edit]

In May 2020, OmniVis was working on the early stages of a rapid test for COVID-19[6] that detects the disease in human saliva. The rapid tests uses a smartphone for processing.[6] The project was supported by the United States Department of Agriculture.[7] From June 2020, OmniVis was also working on a United States National Science Foundation funded initiative to detect COVID-19 from nasal swabs.[8]

References

[edit]
  1. ^ a b c Joe Palca and Susie Neilson (7 Aug 2019). "This Handy New Device Might Help KO Cholera". NPR.org. Retrieved 2021-10-31.
  2. ^ "Purdue Spinout OmniVis Commercializing Smartphone-Based Cholera Test". Genomeweb. 2019-02-15. Retrieved 2021-11-02.
  3. ^ Prashantham, Shameen. Gorillas Can Dance: Lessons from Microsoft and Other Corporations on Partnering with Startups. United Kingdom: Wiley, 2021. p.p. lviii
  4. ^ Service, Purdue News. "'Cholera detection lab' smartphone-enabled platform to be beta tested by worldwide leading hospital in cholera research". www.purdue.edu. Retrieved 2023-11-20.
  5. ^ Coldewey, Devin (2 Oct 2019). "OmniVis could save lives by detecting cholera-infected water in minutes rather than days". TechCrunch. Retrieved 2021-10-31.
  6. ^ a b Marcus, Brianna Abbott and Amy Dockser (2020-05-26). "Race Is On to Create Rapid Covid-19 Tests for the Fall". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-10-31.
  7. ^ "COVID-19 Rapid Response: A Handheld Diagnostic Device for COVID-19 in Meat and Poultry Processing Facilities - OMNIVIS INC". portal.nifa.usda.gov. Retrieved 2021-12-17.
  8. ^ "NSF Award Search: Award # 2028308 - SBIR Phase I: COVID-19 Detection on a Handheld Smartphone-Enabled Platform". www.nsf.gov. Retrieved 2021-12-17.
[edit]